140 related articles for article (PubMed ID: 36281721)
1. Dalbavancin as chronic antibiotic suppression therapy for left ventricular assist device driveline infection due to methicillin-resistant
Pallotto C; Tordi S; Pantanella R; Rosignoli D; Francisci D
J Chemother; 2023 Sep; 35(5):465-469. PubMed ID: 36281721
[TBL] [Abstract][Full Text] [Related]
2. Experience with dalbavancin for long-term antimicrobial suppression of left ventricular assist device infections.
Mansoor AE; Krekel T; Cabrera NL
Transpl Infect Dis; 2023 Aug; 25(4):e14068. PubMed ID: 37159539
[TBL] [Abstract][Full Text] [Related]
3. Eradication of a chronic wound and driveline infection after redo-LVAD implantation.
Walter V; Stock UA; Soriano-Romero M; Schnitzbauer A; Moritz A; Beiras-Fernandez A
J Cardiothorac Surg; 2014 Mar; 9():63. PubMed ID: 24685284
[TBL] [Abstract][Full Text] [Related]
4. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.
Siegenthaler MP; Martin J; Pernice K; Doenst T; Sorg S; Trummer G; Friesewinkel O; Beyersdorf F
Eur J Cardiothorac Surg; 2003 May; 23(5):748-54; discussion 754-5. PubMed ID: 12754028
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of chronic antimicrobial suppression therapy for left ventricular assist device driveline infections: A single-center descriptive experience.
Radcliffe C; Doilicho N; Niu YS; Grant M
Transpl Infect Dis; 2020 Oct; 22(5):e13379. PubMed ID: 32574417
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature.
Levy DT; Steed ME; Rybak MJ; Guo Y; Gialanella P; Hanau L; Muggia V; Ostrowsky B
Transpl Infect Dis; 2012 Oct; 14(5):E89-96. PubMed ID: 22931050
[TBL] [Abstract][Full Text] [Related]
7. Over 870 days of successful antibiotic suppression therapy for VRE-infected left ventricular assist device.
Radcliffe C; Grant M
J Card Surg; 2020 Jul; 35(7):1746-1748. PubMed ID: 32557822
[TBL] [Abstract][Full Text] [Related]
8. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.
Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH
Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices.
Jennings DL; Chopra A; Chambers R; Morgan JA
Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683
[TBL] [Abstract][Full Text] [Related]
10. New Treatment for Driveline Infection Following Implantation of a Ventricular Assist Device.
Sezai A; Unosawa S; Taoka M; Osaka S; Kitazumi Y; Suzuki K; Nakai T; Tanaka M
Heart Surg Forum; 2020 Mar; 23(2):E132-E134. PubMed ID: 32364899
[TBL] [Abstract][Full Text] [Related]
11. Absorbable antibiotic beads for treatment of LVAD driveline infections.
Wadiwala I; Garg P; Alamouti-Fard E; Landolfo K; Sareyyupoglu B; Ahmed ME; Jacob S; Pham S
Artif Organs; 2024 May; 48(5):559-566. PubMed ID: 38400624
[TBL] [Abstract][Full Text] [Related]
12. Therapy and Outcome of Staphylococcus aureus Infections of Intracorporeal Ventricular Assist Devices.
Ekkelenkamp MB; Vervoorn MT; Bayjanov JR; Fluit AC; Benaissa-Trouw BJ; Ramjankhan FZ
Artif Organs; 2018 Oct; 42(10):983-991. PubMed ID: 29675919
[TBL] [Abstract][Full Text] [Related]
13. Oxacillin plus ertapenem rapidly clears persistent left ventricular assist device-related methicillin-susceptible Staphylococcus aureus bacteremia.
Wilsey HA; Pisani B; O'Neill TJ
J Card Surg; 2022 Jul; 37(7):2127-2130. PubMed ID: 35393639
[TBL] [Abstract][Full Text] [Related]
14. Treatment of HeartMate III-LVAD driveline infection by negative pressure wound therapy: Result of our case series.
Cikirikcioglu M; Ponchant K; Murith N; Meyer P; Yilmaz N; Huber C
Int J Artif Organs; 2021 Nov; 44(11):912-916. PubMed ID: 34558333
[TBL] [Abstract][Full Text] [Related]
15. Minimum inhibitory concentration changes in relapsed left ventricular assist device driveline infections.
Lines TH; Sabato LA; Nesbitt WJ; Moretz JD; Brinkley DM; Satyanarayana G
Int J Artif Organs; 2020 Jul; 43(7):494-499. PubMed ID: 31964206
[TBL] [Abstract][Full Text] [Related]
16. Absorbable antibiotic beads as an adjuvant therapy in treating ventricular assist devices driveline infection: A case report.
Haddad O; Pham AN; Thomas M; Ali M; Sareyyupoglu B; El-Sayed Ahmed MM; Pham SM
J Card Surg; 2020 Aug; 35(8):2073-2076. PubMed ID: 32652630
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular assist device-related infections: a multicentric study.
Siméon S; Flécher E; Revest M; Niculescu M; Roussel JC; Michel M; Leprince P; Tattevin P
Clin Microbiol Infect; 2017 Oct; 23(10):748-751. PubMed ID: 28323195
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis.
Juraszek A; Smólski M; Kołsut P; Szymański J; Litwiński P; Kuśmierski K; Zakrzewska-Koperska J; Sterliński M; Dziodzio T; Kuśmierczyk M
J Cardiothorac Surg; 2021 Aug; 16(1):216. PubMed ID: 34344400
[TBL] [Abstract][Full Text] [Related]
19. Ventricular assist device driveline infection: treatment with platelet-rich plasma.
Jiritano F; Serraino GF; Rossi M; Dominijanni A; Brescia A; Renzulli A
Ann Thorac Surg; 2013 Aug; 96(2):e37-8. PubMed ID: 23910142
[TBL] [Abstract][Full Text] [Related]
20. Multiple Weekly Dalbavancin Dosing for the Treatment of Native Vertebral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus Aureus: A Case Report.
Almangour TA; Fletcher V; Alessa M; Alhifany AA; Tabb D
Am J Case Rep; 2017 Dec; 18():1315-1319. PubMed ID: 29222405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
